Researchers Find Recipients of Johnson & Johnson Covid Vaccine are 3.5X More Likely Than General Population to Develop Rare, Deadly Blood Clotting Condition in Brain
A stunning new study that was conducted by researchers from the Mayo Clinic in Rochester, Minnesota has concluded that the Johnson & Johnson Covid vaccine increases the risk of developing a rare and deadly blood clotting condition in the brain.
The study, which was published on Monday in the Journal of the American Medical Association (JAMA), found that recipients of the one-shot J&J vaccine are 3.5 times more likely (8.65 per 100,000) to develop cerebral venous sinus thrombosis (CVST) when compared to the general population (2.34 per 100,000).
“The overall age- and sex-adjusted CVST incidence [within the general population before the Covid-19 outbreak] was 2.34 per 100 000 person-years. Age-adjusted CVST rates for female and male individuals were 2.46 per 100 000 PY and 2.34 per 100 000 PY,
